• Je něco špatně v tomto záznamu ?

Aberrant adaptive immune response underlies genetic susceptibility to tuberculosis

A. Tsareva, PV. Shelyakin, IA. Shagina, MY. Myshkin, EM. Merzlyak, VV. Kriukova, AS. Apt, IA. Linge, DM. Chudakov, OV. Britanova

. 2024 ; 15 (-) : 1380971. [pub] 20240510

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24013957

Mycobacterium tuberculosis (Mtb) remains a major threat worldwide, although only a fraction of infected individuals develops tuberculosis (TB). TB susceptibility is shaped by multiple genetic factors, and we performed comparative immunological analysis of two mouse strains to uncover relevant mechanisms underlying susceptibility and resistance. C57BL/6 mice are relatively TB-resistant, whereas I/St mice are prone to develop severe TB, partly due to the MHC-II allelic variant that shapes suboptimal CD4+ T cell receptor repertoire. We investigated the repertoires of lung-infiltrating helper T cells and B cells at the progressed stage in both strains. We found that lung CD4+ T cell repertoires of infected C57BL/6 but not I/St mice contained convergent TCR clusters with functionally confirmed Mtb specificity. Transcriptomic analysis revealed a more prominent Th1 signature in C57BL/6, and expression of pro-inflammatory IL-16 in I/St lung-infiltrating helper T cells. The two strains also showed distinct Th2 signatures. Furthermore, the humoral response of I/St mice was delayed, less focused, and dominated by IgG/IgM isotypes, whereas C57BL/6 mice generated more Mtb antigen-focused IgA response. We conclude that the inability of I/St mice to produce a timely and efficient anti-Mtb adaptive immune responses arises from a suboptimal helper T cell landscape that also impacts the humoral response, leading to diffuse inflammation and severe disease.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24013957
003      
CZ-PrNML
005      
20240905134153.0
007      
ta
008      
240725e20240510sz f 000 0|eng||
009      
AR
024    7_
$a 10.3389/fimmu.2024.1380971 $2 doi
035    __
$a (PubMed)38799462
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Tsareva, Anastasiia $u Precision Oncology Division, Boston Gene Laboratory, Waltham, MA, United States
245    10
$a Aberrant adaptive immune response underlies genetic susceptibility to tuberculosis / $c A. Tsareva, PV. Shelyakin, IA. Shagina, MY. Myshkin, EM. Merzlyak, VV. Kriukova, AS. Apt, IA. Linge, DM. Chudakov, OV. Britanova
520    9_
$a Mycobacterium tuberculosis (Mtb) remains a major threat worldwide, although only a fraction of infected individuals develops tuberculosis (TB). TB susceptibility is shaped by multiple genetic factors, and we performed comparative immunological analysis of two mouse strains to uncover relevant mechanisms underlying susceptibility and resistance. C57BL/6 mice are relatively TB-resistant, whereas I/St mice are prone to develop severe TB, partly due to the MHC-II allelic variant that shapes suboptimal CD4+ T cell receptor repertoire. We investigated the repertoires of lung-infiltrating helper T cells and B cells at the progressed stage in both strains. We found that lung CD4+ T cell repertoires of infected C57BL/6 but not I/St mice contained convergent TCR clusters with functionally confirmed Mtb specificity. Transcriptomic analysis revealed a more prominent Th1 signature in C57BL/6, and expression of pro-inflammatory IL-16 in I/St lung-infiltrating helper T cells. The two strains also showed distinct Th2 signatures. Furthermore, the humoral response of I/St mice was delayed, less focused, and dominated by IgG/IgM isotypes, whereas C57BL/6 mice generated more Mtb antigen-focused IgA response. We conclude that the inability of I/St mice to produce a timely and efficient anti-Mtb adaptive immune responses arises from a suboptimal helper T cell landscape that also impacts the humoral response, leading to diffuse inflammation and severe disease.
650    _2
$a zvířata $7 D000818
650    _2
$a myši $7 D051379
650    12
$a Mycobacterium tuberculosis $x imunologie $7 D009169
650    12
$a genetická predispozice k nemoci $7 D020022
650    12
$a adaptivní imunita $x genetika $7 D056704
650    12
$a myši inbrední C57BL $7 D008810
650    12
$a tuberkulóza $x imunologie $x genetika $7 D014376
650    _2
$a plíce $x imunologie $x patologie $7 D008168
650    _2
$a B-lymfocyty $x imunologie $7 D001402
650    _2
$a modely nemocí na zvířatech $7 D004195
650    _2
$a receptory antigenů T-buněk $x genetika $x imunologie $7 D011948
655    _2
$a časopisecké články $7 D016428
700    1_
$a Shelyakin, Pavel V $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates
700    1_
$a Shagina, Irina A $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Myshkin, Mikhail Yu $u Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Merzlyak, Ekaterina M $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia
700    1_
$a Kriukova, Valeriia V $u Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
700    1_
$a Apt, Alexander S $u Laboratory for Immunogenetics, Central Tuberculosis Research Institute, Moscow, Russia
700    1_
$a Linge, Irina A $u Laboratory for Immunogenetics, Central Tuberculosis Research Institute, Moscow, Russia
700    1_
$a Chudakov, Dmitriy M $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Abu Dhabi Stem Cells Center, Abu Dhabi, United Arab Emirates $u Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Central European Institute of Technology, Masaryk University, Brno, Czechia
700    1_
$a Britanova, Olga V $u Institute of Translational Medicine, Pirogov Russian National Research Medical University, Moscow, Russia $u Department of Genomics of Adaptive Immunity, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia $u Institute of Clinical Molecular Biology, Christian-Albrechts-University of Kiel, Kiel, Germany
773    0_
$w MED00181405 $t Frontiers in immunology $x 1664-3224 $g Roč. 15 (20240510), s. 1380971
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38799462 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240905134147 $b ABA008
999    __
$a ok $b bmc $g 2143643 $s 1225823
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 15 $c - $d 1380971 $e 20240510 $i 1664-3224 $m Frontiers in immunology $n Front Immunol $x MED00181405
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace